株主資本以外の項目の当期変動額（純額）、その他有価証券評価差額金、Transfer To Retained EarningsSSIFRS他1件
- 【期間】
| 年度 | 株主資本以外の項目の当期変動額（純額） | その他有価証券評価差額金 | Transfer To Retained EarningsSSIFRS | 研究開発費 |
|---|
| 2007/03 | - | | 29.8億 | | - | | - | |
| 2008/03 | -20.1億 | | 8.44億 | -71.7% | - | | - | |
| 2009/03 | -28.2億 | 赤拡 | 0.98億 | -88.4% | - | | - | |
| 2010/03 | 14.3億 | 黒転 | 8.32億 | +749% | - | | - | |
| 2011/03 | -1.96億 | 赤転 | 8.33億 | +0.1% | - | | - | |
| 2012/03 | 4.11億 | 黒転 | 16.6億 | +99% | - | | - | |
| 2013/03 | 22.1億 | +437.2% | 24.7億 | +49.1% | - | | 11.3億 | |
| 2014/03 | - | | 39.9億 | +61.4% | - | | 17.6億 | +55.7% |
| 2015/03 | - | | 49.7億 | +24.6% | - | | 16.9億 | -4.4% |
| 2015/12 | - | | 39.8億 | -20% | - | | 15.4億 | -8.7% |
| 2016/12 | - | | 37.7億 | -5.2% | - | | 15.2億 | -1.4% |
| 2017/12 | - | | 54.2億 | +43.8% | - | | 13.1億 | -14% |
| 2018/12 | - | | 41.6億 | -23.3% | - | | 13.7億 | +5.1% |
| 2019/12 | - | | 43.3億 | +4% | - | | 13億 | -5% |
| 2020/12 | - | | 46億 | +6.2% | - | | 9.17億 | -29.6% |
| 2021/12 | - | | 45億 | -2% | - | | 13.4億 | +45.8% |
| 2022/12 | - | | 48.2億 | +7.1% | - | | 8.89億 | -33.5% |
| 2023/12 | - | | 64.3億 | +33.2% | - | | 17.9億 | +100.9% |
